Gerson SL - Search Results

1

Clinical relevance of MGMT in the treatment of cancer.

Gerson SL. Gerson SL. J Clin Oncol. 2002 May 1;20(9):2388-99. doi: 10.1200/JCO.2002.06.110. J Clin Oncol. 2002. PMID: 11981013 Review.

2

Targeted modulation of MGMT: clinical implications.

Liu L, Gerson SL. Liu L, et al. Among authors: gerson sl. Clin Cancer Res. 2006 Jan 15;12(2):328-31. doi: 10.1158/1078-0432.CCR-05-2543. Clin Cancer Res. 2006. PMID: 16428468 Review.

3

Modulation of O6-alkylguanine alkyltransferase-directed DNA repair in metastatic colon cancers.

Willson JK, Haaga JR, Trey JE, Stellato TA, Gordon NH, Gerson SL. Willson JK, et al. Among authors: gerson sl. J Clin Oncol. 1995 Sep;13(9):2301-8. doi: 10.1200/JCO.1995.13.9.2301. J Clin Oncol. 1995. PMID: 7666087 Clinical Trial.

4

Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients.

Bowman JE, Reese JS, Lingas KT, Gerson SL. Bowman JE, et al. Among authors: gerson sl. Mol Ther. 2003 Jul;8(1):42-50. doi: 10.1016/s1525-0016(03)00141-2. Mol Ther. 2003. PMID: 12842427 Free article.

5

Limited lentiviral transgene expression with increasing copy number in an MGMT selection model: lack of copy number selection by drug treatment.

Zielske SP, Lingas KT, Li Y, Gerson SL. Zielske SP, et al. Among authors: gerson sl. Mol Ther. 2004 Jun;9(6):923-31. doi: 10.1016/j.ymthe.2004.02.017. Mol Ther. 2004. PMID: 15194059 Free article.

6

O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU.

Phillips WP Jr, Willson JK, Markowitz SD, Zborowska E, Zaidi NH, Liu L, Gordon NH, Gerson SL. Phillips WP Jr, et al. Among authors: gerson sl. Cancer Res. 1997 Nov 1;57(21):4817-23. Cancer Res. 1997. PMID: 9354444

7

Base excision repair as a therapeutic target in colon cancer.

Liu L, Nakatsuru Y, Gerson SL. Liu L, et al. Among authors: gerson sl. Clin Cancer Res. 2002 Sep;8(9):2985-91. Clin Cancer Res. 2002. PMID: 12231545

8

Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and tumors of patients after treatment with O(6)-benzylguanine.

Liu L, Spiro TP, Qin X, Majka S, Haaga J, Schupp J, Willson JK, Gerson SL. Liu L, et al. Among authors: gerson sl. Clin Cancer Res. 2001 Aug;7(8):2318-24. Clin Cancer Res. 2001. PMID: 11489807

9

Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide.

Reese JS, Davis BM, Liu L, Gerson SL. Reese JS, et al. Among authors: gerson sl. Clin Cancer Res. 1999 Jan;5(1):163-9. Clin Cancer Res. 1999. PMID: 9918215

10

Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro.

Zielske SP, Gerson SL. Zielske SP, et al. Among authors: gerson sl. Mol Ther. 2002 Apr;5(4):381-7. doi: 10.1006/mthe.2002.0571. Mol Ther. 2002. PMID: 11945064 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters